Oxford Nanopore Technologies reported first-half revenue growth below its expectations as declines in China, the Middle East and delayed orders in the Americas weighed on performance, while gross-margin expansion and lower operating expenses narrowed its adjusted EBITDA loss. Revenue for the first half totaled £116.7 million, up 12.3% at constant currency, with China revenue down about 16% and Middle East revenue down about 14%. Gross margin expanded to 62.2%, adjusted operating expenses fell 7%, and the adjusted EBITDA loss narrowed 54% to £22.1 million. Net cash stood at £234.5 million at period-end, and the company maintained its 2026 core-business growth target of 16% to 20%. A new licensing deal adds a $20 million second-half upfront fee, potential future royalties and reported 2026 growth of 23% to 27% including the fee.
Oxford Nanopore Technologies LtdH1 revenue growth missed expectations due to declines in China and Middle East and delayed orders in Americas.
Onterris